Background and ObjectivesParkinson disease (PD) is a progressive neurodegenerative disorder increasingly linked to gut microbiota dysbiosis, which may influence disease mechanisms and symptom expre...
31 July 2026 in Journal of Clinical Psychopharmacology
Background: Alpha-lipoic acid (ALA) is an antioxidant proposed to mitigate metabolic burden and psychopathology in schizophrenia. We systematically reviewed the efficacy and safety of ALA as an adjunct to antipsychotics. Methods: We searched MEDLINE, Embase, and the Cochrane Library from inception to September 2025 for human studies evaluating ALA in individuals with schizophrenia. Random-effects meta-analyses pooled mean differences (MDs) with 95% CIs for continuous outcomes and pooled proportions for adverse events and discontinuation. Results: Eight studies (n = 165) were included. In single-arm analyses, ALA showed no significant improvements in PANSS scores in pooled estimates, despite isolated findings in small subsets. A reduction in BMI was observed in the RCT subgroup but not in the overall analysis. No significant effects were found for HbA1c, waist circumference, or lipid profile. In ALA versus placebo comparisons, no significant differences were observed for PANSS scores, BMI, adverse events, or discontinuation. ALA was generally well tolerated, though findings were limited by small sample sizes and imprecision. Conclusions: Current evidence suggests adjunctive ALA may modestly influence selected PANSS subscales but does not improve metabolic outcomes. Larger, well-designed trials with standardized dosing and longer follow-up are needed to clarify clinical relevance and safety.
29 August 2026 in Seizure: European Journal of Epilepsy
Objetivo: Analisar a prevalência e fatores associados à ideação suicida entre enfermeiros antes, durante e após a pandemia da COVID-19. Método: Protocolo de revisão sistemática, seguindo as diretrizes do Joanna Briggs Institute e do Preferred Reporting Items for Systematic Reviews and Meta-Analyses. As buscas serão realizadas em seis fontes de busca: MEDLINE/PubMed, SCOPUS, EMBASE, LILACS, Cochrane Central e Google Acadêmico. Serão incluídos estudos com enfermeiros que desenvolveram ideação suicida ocorrendo em serviços de saúde, antes, durante e após a COVID-19. A seleção dos estudos, revisão de dados e avaliação crítica serão realizadas de forma independente por dois revisores, com um terceiro para resolver discrepâncias. Propõe-se desenvolver uma descrição estatística com metanálise, se adequada. Resultados esperados: Espera-se identificar a prevalência de ideação suicida e seus fatores associados entre enfermeiros, fornecendo subsídios para o desenvolvimento de políticas públicas para a saúde do trabalhador e estratégias de saúde mental.